Pancreatic Islet Cell Differentiation With Targeted Metabolite Supplementation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The shortage of pancreatic islet donors hinders the effective implementation of pancreatic islet transplantation for treating diabetes, necessitating alternative methods to produce islet cells with functional characteristics resembling endogenous pancreatic islets.
Innovation Solution
A method involving the use of pluripotent stem cells supplemented with specific metabolites like aspartate, glycine, and serine, along with TGF-β ligands and PI3K/Akt/mTOR signaling inhibitors, to enhance the production of NKX6.1-positive, ISL1-positive cells, resulting in a population with at least 50% of these cells and less than 20% ISL1-negative cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional differentiation methods are used without metabolite supplementation, then the differentiation process is simpler, but the production efficiency of functional β cells is low
Solution Approach 1:
The patent applies parameter changes by optimizing the concentrations of specific metabolites (aspartate, glycine, serine) in the differentiation medium. By adjusting these chemical parameters within specific ranges, the method enhances β cell production efficiency without fundamentally changing the differentiation protocol structure, thus resolving the contradiction between productivity improvement and process complexity
Solution Approach 2:
The patent copies the metabolic profile of endogenous pancreatic islet development by supplementing with metabolites that mimic natural developmental conditions. This copying approach allows in vitro differentiation to better replicate in vivo processes, improving β cell functional characteristics while maintaining a relatively simple medium supplementation strategy
2Manufacturing precision
If metabolite supplementation is added to enhance β cell production, then the differentiation efficiency improves, but the medium composition becomes more complex
Solution Approach 1:
The patent applies local quality by selectively supplementing only three specific metabolites (aspartate, glycine, serine) at optimized concentrations rather than adding a broad spectrum of nutrients. This targeted approach improves differentiation efficiency by addressing specific metabolic requirements of β cell development while minimizing unnecessary complexity in the medium composition
3Manufacturing precision
If the goal is to produce high proportions of NKX6.1-positive, ISL1-positive cells, then the quality of islet cell population improves, but the production process becomes more demanding
Solution Approach 1:
The patent uses parameter changes by optimizing metabolite concentrations to shift the differentiation outcome toward higher proportions of NKX6.1-positive, ISL1-positive β cells. This chemical parameter optimization achieves improved cell population quality without requiring complex process controls or multiple differentiation stages, thereby maintaining ease of manufacture
Data Source
AI summary
Disclosed herein are compositions and methods related to differentiation of stem cells into pancreatic islet cells. In some aspects, the methods provided herein relate to generation of pancreatic β cell, α cell, δ cells, and EC cells in vitro. In some aspects, the disclosure provides pharmaceutical compositions including the cells generated according to the methods disclosed herein, as well as methods of treatment making use thereof.